Literature DB >> 19589525

Risk factors for obstetric fistula in the Far North Province of Cameroon.

Pierre Marie Tebeu1, Luc de Bernis, Anderson Sama Doh, Charles Henry Rochat, Thérèse Delvaux.   

Abstract

OBJECTIVE: To describe the circumstances of occurrence and identify potential risk factors for obstetric fistula in northern Cameroon.
METHODS: A case series study of 42 obstetric fistula patients seeking services at the Provincial Hospital of Maroua, Cameroon, between May 2005 and August 2007. Structured interviews were conducted prior to surgical intervention.
RESULTS: Among obstetric fistula patients, 60% had lived with obstetric fistula for more than 5 years at the time of surgery. Eighty-one percent of patients had received no formal education and 86% were teenagers at their first delivery. Regarding the pregnancy and delivery preceding the occurrence of the fistula, 50% of women reported that they had received no prenatal care and 76% were in labor for more than 12 hours. The majority (83%) of women delivered a stillborn baby.
CONCLUSIONS: Obstetric fistula patients in the Far North Province of Cameroon had a low level of education, were married at a young age, and had poor access to quality maternal healthcare services.

Entities:  

Mesh:

Year:  2009        PMID: 19589525     DOI: 10.1016/j.ijgo.2009.05.019

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  15 in total

1.  Laparoscopic repair of iatrogenic vesicovaginal and rectovaginal fistula.

Authors:  Lei Chu; Jian-Jun Wang; Li Li; Xiao-Wen Tong; Bo-Zhen Fan; Yi Guo; Huai-Fang Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Presentation and management of rectovaginal fistulas after delivery.

Authors:  Christl Reisenauer
Journal:  Int Urogynecol J       Date:  2015-10-17       Impact factor: 2.894

3.  Impact of surgery on quality of life of women with obstetrical fistula: a qualitative study in Burkina Faso.

Authors:  Julie Désalliers; Marie-Eve Paré; Salam Kouraogo; Jacques Corcos
Journal:  Int Urogynecol J       Date:  2016-12-26       Impact factor: 2.894

4.  Obstetric vesico-vaginal fistulae seen in the Northern Democratic Republic of Congo: a descriptive study.

Authors:  Justin L Paluku; Tamar E Carter
Journal:  Afr Health Sci       Date:  2015-12       Impact factor: 0.927

5.  Quality care in vesico-vaginal obstetric fistula: case series report from the regional hospital of Maroua-Cameroon.

Authors:  Pierre Marie Tebeu; Joseph Nelson Fomulu; Achille Aurelien Mbassi; Jean Marie Tcheliebou; Anderson Sama Doh; Charles Henry Rochat
Journal:  Pan Afr Med J       Date:  2010-04-27

Review 6.  Overcoming phase 1 delays: the critical component of obstetric fistula prevention programs in resource-poor countries.

Authors:  L Lewis Wall
Journal:  BMC Pregnancy Childbirth       Date:  2012-07-18       Impact factor: 3.007

7.  Laparoscopic fistula excision and omentoplasty for high rectovaginal fistulas: a prospective study of 40 patients.

Authors:  Stephan J van der Hagen; Peter B Soeters; Cor G Baeten; Wim G van Gemert
Journal:  Int J Colorectal Dis       Date:  2011-06-24       Impact factor: 2.571

8.  "I am nothing": experiences of loss among women suffering from severe birth injuries in Tanzania.

Authors:  Lilian T Mselle; Karen Marie Moland; Bjørg Evjen-Olsen; Abu Mvungi; Thecla W Kohi
Journal:  BMC Womens Health       Date:  2011-11-15       Impact factor: 2.809

Review 9.  Risk factors for obstetric fistula: a clinical review.

Authors:  Pierre Marie Tebeu; Joseph Nelson Fomulu; Sinan Khaddaj; Luc de Bernis; Thérèse Delvaux; Charles Henry Rochat
Journal:  Int Urogynecol J       Date:  2011-12-06       Impact factor: 2.894

Review 10.  Obstetric fistula in low-resource countries: an under-valued and under-studied problem--systematic review of its incidence, prevalence, and association with stillbirth.

Authors:  Karen D Cowgill; Jennifer Bishop; Amanda K Norgaard; Craig E Rubens; Michael G Gravett
Journal:  BMC Pregnancy Childbirth       Date:  2015-08-26       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.